Taxotere Frequently Asked Questions
What is Taxotere (docetaxel)?
Taxotere is a cancer medication that interferes with the growth and spread of cancer cells in the body. As a chemotherapy drug, Taxotere is used to treat several forms of cancer, including breast cancer, lung cancer, prostate cancer and stomach cancer. Taxotere is manufactured by French pharmaceutical company Sanofi-Aventis, and its generic drug name is docetaxel.
How is Taxotere given?
During cancer treatment, Taxotere is usually injected into the veins as a concentrate once every three weeks by a healthcare professional. Taxotere is administered in patients for as long as the chemotherapy treatment persists. As many as an estimated 75% of women who undergo chemotherapy to treat breast cancer receive Taxotere.
What is Taxotere hair loss?
Taxotere is currently being investigated for its connection to hair loss, particularly in women who receive the drug during breast cancer treatment. Women have reported severe permanent hair loss, or alopecia, associated with Taxotere. Many women claim they were told the hair loss would be temporary. According to a 2013 study by the National Cancer Research Institute, as many as 15% of women who were given Taxotere have experienced permanent hair loss.
Why are women filing Taxotere hair loss lawsuits?
Taxotere manufacturer Sanofi-Aventis may have known that the drug could be associated with an increased risk of permanent hair loss, but failed to warn doctors and patients. Many patients were led to believe their hair would return after stopping use of Taxotere. Taxotere is not the only available drug in treating chemotherapy, and alternatives have been found to have a negligible risk of permanent alopecia.